HEALIOS K K (HLOSF, $1.35) was a top loser over the last three months, falling -2 to $1.35 per share. A.I.dvisor analyzed 863 stocks in the Biotechnology Industry for the 3-month period ending December 2, 2024, and found that of them (4) exhibited an Uptrend while of them (5) demonstrated a Downtrend.